FDA LABEL RECORD
Cyclosporine
CYCLOSPORINE. FDA prescribing information for this product, as published on the retrieval date below.
AS THE LABEL RECORDS IT
Product details
| Brand name | Cyclosporine |
|---|---|
| Generic name | CYCLOSPORINE |
| Labeller | Mylan Pharmaceuticals Inc. |
| Route | OPHTHALMIC |
| Label version | 1 |
| Effective | 2022-01-20 |
| Retrieved by this site | 2026-08-31 |
| Full label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da3fa070-b512-4568-871a-dc8d5a949d13 |
INDICATIONS AND USAGE
Quoted from the FDA label
1 INDICATIONS AND USAGE Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. Cyclosporine ophthalmic emulsion is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. ( 1 )
What this page is
A reproduction of a public FDA label record. Everything quoted above is the labeller's wording as published by the FDA, not this site's. Nothing here is regulatory, legal or medical advice, and a label being reproduced says nothing about whether a product is available in any particular country. Labels are revised often; the retrieval date above says when this copy was taken, and the full current label is at the link.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.